Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for ...

Bionano projects full-year 2025 revenues to be in the range of $29 million to $32 million, supported by its strategic focus on routine users. First-quarter 2025 revenues are expected to range from ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue ...

Shareholders will be ecstatic, with their stake up 20% over the past week following Bionano Genomics, Inc.'s (NASDAQ:BNGO) latest full-year results. The results don't look great, especially ...

In-Motion Webinar: Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential ...

Bionano will host a webinar on optical genome mapping's implications for acute myeloid leukemia, featuring Dr. Guilin Tang's insights. Bionano Genomics, Inc. has announced a webinar to be held on ...

SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American College of Medical Genetics and Genomics (ACMG) Annual ...

SAN DIEGO, March 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in the American Journal of Hematology demonstrating the potential utility of ...